Latest Earnings Analysis

• Syndax (SNDX) Q4 2025: Revuforge Net Revenue Climbs 38% on Expanded AML Penetration
  February 27, 2026 · SNDX
• Strategic Education (STRA) Q4 2025: ETS Grows 40%, Now One-Third of Operating Income
  February 27, 2026 · STRA
• Enlight (LASR) Q4 2025: A&D Revenue Soars 87% as Focus Shifts to Defense Growth
  February 27, 2026 · LASR
• Applied Optoelectronics (AAOI) Q4 2025: 800G Ramp to $25M+ Drives Capacity-Limited Surge
  February 27, 2026 · AAOI
• Royal Bank of Canada (RY) Q1 2026: Record $6B Wealth Revenue and 13% AUA Growth Signal Fee-Based Shift
  February 27, 2026 · RY
• Amphastar (AMPH) Q4 2025: Ipratropium Bromide HFA Approval Unlocks 180 Days of Market Exclusivity
  February 27, 2026 · AMPH
• Delcath Systems (DCTH) Q4 2025: R&D Spend to Rise 90% as Site Activations and Chopin Data Set Stage for 2026 Expansion
  February 27, 2026 · DCTH
• ICG (ICG) Q4 2025: ETH Holdings Up 56% as Mining Revenue Softens and Staking Expands
  February 27, 2026 · ICG
• Technova (TKNO) Q4 2025: Clinical Solutions Revenue Jumps 47% as Biotech Pipeline Builds
  February 27, 2026 · TKNO
• Compass (COMP) Q4 2025: $175M Synergy Actions Signal Accelerated Integration and Margin Upside
  February 27, 2026 · COMP
• SoundHound (SOUN) Q4 2025: Agentic AI Drives 59% Revenue Surge and Expands Containment Rates Above 90%
  February 27, 2026 · SOUN
• Alignment Healthcare (ALHC) Q4 2025: Membership Jumps 25% as Margin Expansion Outpaces Industry
  February 27, 2026 · ALHC
• Fathom Pharmaceuticals (PHAT) Q4 2025: Revenue Jumps 217% as GI Focus Drives Prescription Adoption
  February 27, 2026 · PHAT
• Ginkgo Bioworks (DNA) Q4 2025: Cash Burn Cut 55% as Autonomous Lab Focus Reshapes Strategy
  February 27, 2026 · DNA
• Clipper Realty (CLPR) Q4 2025: Residential Rents Jump 13% as Office Drag Deepens
  February 27, 2026 · CLPR
• Cable One (CABO) Q4 2025: $403M Debt Paydown Reshapes Balance Sheet Amid Broadband Headwinds
  February 27, 2026 · CABO
• Ambarella (AMBA) Q4 2026: HAI Revenue Hits 80% of Mix, Channel and ASIC Bets Shape FY27
  February 27, 2026 · AMBA
• Clover Health (CLOV) Q4 2025: Membership Jumps 38% as Cohort Economics Drive First GAAP Profit Path
  February 27, 2026 · CLOV
• Arlo (ARLO) Q4 2025: Services Revenue Hits 63% of Total, Cementing SaaS Margin Expansion
  February 27, 2026 · ARLO
• Heron Therapeutics (HRTX) Q4 2025: Acute Care Franchise Surges 57% as Commercial Expansion Accelerates
  February 27, 2026 · HRTX
• NERDY (NRDY) Q4 2025: Gross Margin Expands 380bps as AI-Native Platform Drives Structural Turn
  February 27, 2026 · NRDY
• Sweetgreen (SG) Q4 2025: Wraps Test Drives New Customer Growth as Comp Guidance Signals -4% Headwind
  February 27, 2026 · SG
• Alta Equipment Group (ALTG) Q4 2025: Equipment Sales Jump $90M Sequentially as Inventory Pressures Ease
  February 27, 2026 · ALTG
• Progeny (PGNY) Q4 2025: Gross Margin Expands 200bps as Cost Control Offsets Membership Volatility
  February 27, 2026 · PGNY
• H2O America (HTO) Q4 2025: CapEx Surges 41%, Setting $2.7B Five-Year Investment Cycle
  February 27, 2026 · HTO
• Globant (GLOB) Q4 2025: AI Pods Pipeline Jumps 34% as Execution Phase Drives Structural Shift
  February 27, 2026 · GLOB
• Castle Biosciences (CSTL) Q4 2025: TissueCypher Volume Soars 86%, Reinforcing GI Franchise Trajectory
  February 27, 2026 · CSTL
• TPC Q4 2025: Operating Cash Flow Surges 49% as Civil Backlog Drives Visibility
  February 27, 2026 · TPC
• Sprout Social (SPT) Q4 2025: 22% Growth in 30K+ Customer Revenue Sets Foundation for Margin Expansion
  February 27, 2026 · SPT
• ICFI Q4 2025: Commercial Energy Surges 24%, Non-Federal Mix Hits 62% as Federal Headwinds Ease
  February 27, 2026 · ICFI
• PACS (PACS) Q4 2025: 31% Revenue Growth Anchored by 106-Facility Acquisition Surge
  February 27, 2026 · PACS
• Monster Beverage (MNST) Q4 2025: International Sales Jump 27% as Affordable Energy Strategy Scales
  February 27, 2026 · MNST
• Rocket Lab (RKLB) Q4 2025: Backlog Surges 69% as SDA Win Anchors Multi-Year Visibility
  February 27, 2026 · RKLB
• SEER (SEER) Q4 2025: Installed Base Jumps 67% as Proteograph Adoption Outpaces Funding Headwinds
  February 27, 2026 · SEER
• Scitech Biosciences (CTKB) Q4 2025: Recurring Revenue Jumps 21% as Installed Base Expands
  February 27, 2026 · CTKB
• Zscaler (ZS) Q2 2026: Non-Seat Metered Solutions Exceed 25% of New ACV, Fueling Platform Expansion
  February 27, 2026 · ZS
• TLN Q4 2025: Free Cash Flow Surges 2x as Data Center Demand and Contracted Cash Flows Accelerate
  February 27, 2026 · TLN
• AEVA (AEVA) Q4 2025: Revenue Doubles as Top-Tier OEM and NVIDIA Awards Expand $80B Pipeline
  February 27, 2026 · AEVA
• DoubleVerify (DV) Q4 2025: Social Activation Soars 60% as Product Mix Shifts Toward AI and CTV
  February 27, 2026 · DV
• Baldwin Group (BWIN) Q4 2025: UCTS Delivers 16% Organic Growth, Showcasing Embedded Platform Resilience
  February 27, 2026 · BWIN
• OneSpan (OSPN) Q4 2025: Software Share Rises to 80% as Hardware Decline Moderates
  February 27, 2026 · OSPN
• Gray Media (GTN) Q4 2025: Net Retransmission Revenue Returns to Growth, Signaling Model Stabilization
  February 27, 2026 · GTN
• STRZ Q4 2025: OTT Subscribers Hit 12.7M, Free Cash Flow to Jump $120M in 2026
  February 27, 2026 · STRZ
• Definitive Healthcare (DH) Q4 2025: 200 Bps Retention Gain Signals Stabilization, But Revenue Guides Down 6-9%
  February 27, 2026 · DH
• MARA (MARA) Q4 2025: Starwood JV Unlocks 2.5 GW AI Compute Path, Pivoting Beyond Bitcoin Mining
  February 27, 2026 · MARA
• EBS Q4 2025: Net Leverage Cut to 1.9x as Cash Flow Surges and Margin Expands
  February 27, 2026 · EBS
• ASUR Q4 2025: Recurring Revenue Climbs to 91%, AI and Attach Rates Reshape Growth Trajectory
  February 27, 2026 · ASUR
• KEP (KEP) Q4 2025: Nuclear Capacity Factor Set to Rise as Fuel Costs Drop 13.8%
  February 27, 2026 · KEP
• Sunrun (RUN) Q4 2025: Storage Attachment Rate Climbs to 71%, Anchoring Margin-First Strategy
  February 27, 2026 · RUN
• PACIRA (PCRX) Q4 2025: 102M Covered Lives Drive XBRL Access Surge, Margin Expansion On Track
  February 27, 2026 · PCRX